Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer: A Randomized Controlled Trial
National Cancer Institute, Egypt
70 participants
Jan 24, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.
Eligibility
Inclusion Criteria4
- Age \> 18 years and ≤ 65 years old.
- American Society of Anesthesiologists (ASA) physical status II-III.
- Body mass index 18-35 kg/m2.
- Patients scheduled for thoracotomies for lung cancer.
Exclusion Criteria8
- Patient refusal.
- History of sensitivity to local anesthetics.
- History of psychological disorders.
- Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
- Severe respiratory, cardiac, hepatic, or renal disease.
- Morbid obesity.
- Uncooperative patients.
- Patients on chronic pain therapy.
Interventions
Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.
Patients will receive an ipsilateral ultrasound-guided thoracic paravertebral plane block with injection of 20 ml bupivacaine 0.25%.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07367581